Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Uracil-2-13c
2. 35803-45-3
3. Uracil (2-13c)
4. Uracil-(2-13c)
5. (213c)1h-pyrimidine-2,4-dione
6. Uracil (2-13c) [jan]
7. Ozf8j4vaik
8. 2,4(1h,3h)-pyrimidinedione-2-13c
9. Uracil-[2-13c]
10. Uracil (2-13c) (jan)
11. Unii-ozf8j4vaik
12. 2-uracil C-13
13. 13c-uracil
14. Uracil 2c-13
15. Dtxsid70189336
16. Chebi:177594
17. Mfcd00084096
18. Akos015913159
19. Uracil-2-13c, 99 Atom % 13c
20. D09776
21. Q27285932
| Molecular Weight | 113.08 g/mol |
|---|---|
| Molecular Formula | C4H4N2O2 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 113.030632210 g/mol |
| Monoisotopic Mass | 113.030632210 g/mol |
| Topological Polar Surface Area | 58.2 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 161 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Uracil-2-13C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Uracil-2-13C, including repackagers and relabelers. The FDA regulates Uracil-2-13C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Uracil-2-13C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Uracil-2-13C supplier is an individual or a company that provides Uracil-2-13C active pharmaceutical ingredient (API) or Uracil-2-13C finished formulations upon request. The Uracil-2-13C suppliers may include Uracil-2-13C API manufacturers, exporters, distributors and traders.
click here to find a list of Uracil-2-13C suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Uracil-2-13C DMF (Drug Master File) is a document detailing the whole manufacturing process of Uracil-2-13C active pharmaceutical ingredient (API) in detail. Different forms of Uracil-2-13C DMFs exist exist since differing nations have different regulations, such as Uracil-2-13C USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Uracil-2-13C DMF submitted to regulatory agencies in the US is known as a USDMF. Uracil-2-13C USDMF includes data on Uracil-2-13C's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Uracil-2-13C USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Uracil-2-13C suppliers with USDMF on PharmaCompass.
Uracil-2-13C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Uracil-2-13C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Uracil-2-13C GMP manufacturer or Uracil-2-13C GMP API supplier for your needs.
A Uracil-2-13C CoA (Certificate of Analysis) is a formal document that attests to Uracil-2-13C's compliance with Uracil-2-13C specifications and serves as a tool for batch-level quality control.
Uracil-2-13C CoA mostly includes findings from lab analyses of a specific batch. For each Uracil-2-13C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Uracil-2-13C may be tested according to a variety of international standards, such as European Pharmacopoeia (Uracil-2-13C EP), Uracil-2-13C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Uracil-2-13C USP).
LOOKING FOR A SUPPLIER?
